Global Renal Denervation Therapy Industry

2023-2029 Global Renal Denervation (RDN) Therapy Industry Research & Trends Analysis Report

Global Renal Denervation Therapy Industry

2023-2029 Global Renal Denervation (RDN) Therapy Industry Research & Trends Analysis Report


The Renal Denervation (RDN) Therapy Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to the research report, the global market for Renal Denervation (RDN) Therapy should grow from US$ 937.5 million in 2022 to US$ 8023.6 million by 2029, with a CAGR of 36.4% for the period of 2023-2029.

China Renal Denervation (RDN) Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Renal Denervation (RDN) Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Radio Frequency segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Renal Denervation (RDN) Therapy include Medtronic (Covidien), ReCor, Johnson & Johnson, Boston Scientific, Shanghai Golden Leaf Med Tec Co., Ltd, Bio-Heart, SyMap Medical, Venus Medtech and Shanghai Microport Ep Medtech Co.,Ltd., etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Renal Denervation (RDN) Therapy.
Report Highlights:

(1) Global Renal Denervation (RDN) Therapy market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Renal Denervation (RDN) Therapy market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Renal Denervation (RDN) Therapy market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Renal Denervation (RDN) Therapy segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Renal Denervation (RDN) Therapy segment by type and by application and regional segment by type and by application.

(6) Renal Denervation (RDN) Therapy industry supply chain, upstream, midstream and downstream analysis.


Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa


Market segment by type, covers

Radio Frequency

Ultrasonic


Market segment by application, can be divided into

Hospital

Clinic

Other


Market segment by players, this report covers

Medtronic (Covidien)

ReCor

Johnson & Johnson

Boston Scientific

Shanghai Golden Leaf Med Tec Co., Ltd

Bio-Heart

SyMap Medical

Venus Medtech

Shanghai Microport Ep Medtech Co.,Ltd.

Cryofocus Medtech


Key Reasons to Purchase:

☑ To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape.

☑ Assess the production processes, major issues, and solutions to mitigate the development risk.

☑ To understand the most affecting driving and restraining forces in the market and their impact on the global market.

☑ To understand the future outlook and prospects for the market.

☑ Besides the standard structure reports, we also provide custom research according to specific requirements.

1 Market Overview

1.1 Product Overview and Scope of Renal Denervation (RDN) Therapy

1.2 Global Renal Denervation (RDN) Therapy Market Size and Forecast

1.3 China Renal Denervation (RDN) Therapy Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Renal Denervation (RDN) Therapy Share in Global Market, 2018-2029

1.4.2 Renal Denervation (RDN) Therapy Market Size: China VS Global, 2018-2029

1.5 Renal Denervation (RDN) Therapy Market Dynamics

1.5.1 Renal Denervation (RDN) Therapy Market Drivers

1.5.2 Renal Denervation (RDN) Therapy Market Restraints

1.5.3 Renal Denervation (RDN) Therapy Industry Trends

1.5.4 Renal Denervation (RDN) Therapy Industry Policy

2 Global Competitive Situation by Company

2.1 Global Renal Denervation (RDN) Therapy Revenue by Company (2018-2023)

2.2 Global Renal Denervation (RDN) Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Renal Denervation (RDN) Therapy Concentration Ratio

2.4 Global Renal Denervation (RDN) Therapy Mergers & Acquisitions, Expansion Plans

2.5 Global Renal Denervation (RDN) Therapy Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Renal Denervation (RDN) Therapy Revenue by Company (2018-2023)

3.2 China Renal Denervation (RDN) Therapy Renal Denervation (RDN) Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Renal Denervation (RDN) Therapy, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Renal Denervation (RDN) Therapy Industry Chain

4.2 Renal Denervation (RDN) Therapy Upstream Analysis

4.3 Renal Denervation (RDN) Therapy Midstream Analysis

4.4 Renal Denervation (RDN) Therapy Downstream Analysis

5 Sights by Type

5.1 Renal Denervation (RDN) Therapy Classification

5.1.1 Radio Frequency

5.1.2 Ultrasonic

5.2 By Type, Global Renal Denervation (RDN) Therapy Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Renal Denervation (RDN) Therapy Revenue, 2018-2029

6 Sights by Application

6.1 Renal Denervation (RDN) Therapy Segment by Application

6.1.1 Hospital

6.1.2 Clinic

6.1.3 Other

6.2 By Application, Global Renal Denervation (RDN) Therapy Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Renal Denervation (RDN) Therapy Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Renal Denervation (RDN) Therapy Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Renal Denervation (RDN) Therapy Market Size, 2018-2029

7.3 North America

7.3.1 North America Renal Denervation (RDN) Therapy Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Renal Denervation (RDN) Therapy Market Size Market Share

7.4 Europe

7.4.1 Europe Renal Denervation (RDN) Therapy Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Renal Denervation (RDN) Therapy Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Renal Denervation (RDN) Therapy Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Renal Denervation (RDN) Therapy Market Size Market Share

7.6 South America

7.6.1 South America Renal Denervation (RDN) Therapy Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Renal Denervation (RDN) Therapy Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Renal Denervation (RDN) Therapy Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Renal Denervation (RDN) Therapy Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Renal Denervation (RDN) Therapy Market Size, 2018-2029

8.3.2 By Company, U.S. Renal Denervation (RDN) Therapy Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Renal Denervation (RDN) Therapy Market Size, 2018-2029

8.4.2 By Company, Europe Renal Denervation (RDN) Therapy Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Renal Denervation (RDN) Therapy Market Size, 2018-2029

8.5.2 By Company, China Renal Denervation (RDN) Therapy Revenue Market Share, 2018-2023

8.5.3 By Type, China Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Renal Denervation (RDN) Therapy Market Size, 2018-2029

8.6.2 By Company, Japan Renal Denervation (RDN) Therapy Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Renal Denervation (RDN) Therapy Market Size, 2018-2029

8.7.2 By Company, South Korea Renal Denervation (RDN) Therapy Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Renal Denervation (RDN) Therapy Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Renal Denervation (RDN) Therapy Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Renal Denervation (RDN) Therapy Market Size, 2018-2029

8.9.2 By Company, India Renal Denervation (RDN) Therapy Revenue Market Share, 2018-2023

8.9.3 By Type, India Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Renal Denervation (RDN) Therapy Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Renal Denervation (RDN) Therapy Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Renal Denervation (RDN) Therapy Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Medtronic (Covidien)

9.1.1 Medtronic (Covidien) Company Information, Head Office, Market Area and Industry Position

9.1.2 Medtronic (Covidien) Company Profile and Main Business

9.1.3 Medtronic (Covidien) Renal Denervation (RDN) Therapy Models, Specifications and Application

9.1.4 Medtronic (Covidien) Renal Denervation (RDN) Therapy Revenue and Gross Margin, 2018-2023

9.1.5 Medtronic (Covidien) Recent Developments

9.2 ReCor

9.2.1 ReCor Company Information, Head Office, Market Area and Industry Position

9.2.2 ReCor Company Profile and Main Business

9.2.3 ReCor Renal Denervation (RDN) Therapy Models, Specifications and Application

9.2.4 ReCor Renal Denervation (RDN) Therapy Revenue and Gross Margin, 2018-2023

9.2.5 ReCor Recent Developments

9.3 Johnson & Johnson

9.3.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

9.3.2 Johnson & Johnson Company Profile and Main Business

9.3.3 Johnson & Johnson Renal Denervation (RDN) Therapy Models, Specifications and Application

9.3.4 Johnson & Johnson Renal Denervation (RDN) Therapy Revenue and Gross Margin, 2018-2023

9.3.5 Johnson & Johnson Recent Developments

9.4 Boston Scientific

9.4.1 Boston Scientific Company Information, Head Office, Market Area and Industry Position

9.4.2 Boston Scientific Company Profile and Main Business

9.4.3 Boston Scientific Renal Denervation (RDN) Therapy Models, Specifications and Application

9.4.4 Boston Scientific Renal Denervation (RDN) Therapy Revenue and Gross Margin, 2018-2023

9.4.5 Boston Scientific Recent Developments

9.5 Shanghai Golden Leaf Med Tec Co., Ltd

9.5.1 Shanghai Golden Leaf Med Tec Co., Ltd Company Information, Head Office, Market Area and Industry Position

9.5.2 Shanghai Golden Leaf Med Tec Co., Ltd Company Profile and Main Business

9.5.3 Shanghai Golden Leaf Med Tec Co., Ltd Renal Denervation (RDN) Therapy Models, Specifications and Application

9.5.4 Shanghai Golden Leaf Med Tec Co., Ltd Renal Denervation (RDN) Therapy Revenue and Gross Margin, 2018-2023

9.5.5 Shanghai Golden Leaf Med Tec Co., Ltd Recent Developments

9.6 Bio-Heart

9.6.1 Bio-Heart Company Information, Head Office, Market Area and Industry Position

9.6.2 Bio-Heart Company Profile and Main Business

9.6.3 Bio-Heart Renal Denervation (RDN) Therapy Models, Specifications and Application

9.6.4 Bio-Heart Renal Denervation (RDN) Therapy Revenue and Gross Margin, 2018-2023

9.6.5 Bio-Heart Recent Developments

9.7 SyMap Medical

9.7.1 SyMap Medical Company Information, Head Office, Market Area and Industry Position

9.7.2 SyMap Medical Company Profile and Main Business

9.7.3 SyMap Medical Renal Denervation (RDN) Therapy Models, Specifications and Application

9.7.4 SyMap Medical Renal Denervation (RDN) Therapy Revenue and Gross Margin, 2018-2023

9.7.5 SyMap Medical Recent Developments

9.8 Venus Medtech

9.8.1 Venus Medtech Company Information, Head Office, Market Area and Industry Position

9.8.2 Venus Medtech Company Profile and Main Business

9.8.3 Venus Medtech Renal Denervation (RDN) Therapy Models, Specifications and Application

9.8.4 Venus Medtech Renal Denervation (RDN) Therapy Revenue and Gross Margin, 2018-2023

9.8.5 Venus Medtech Recent Developments

9.9 Shanghai Microport Ep Medtech Co.,Ltd.

9.9.1 Shanghai Microport Ep Medtech Co.,Ltd. Company Information, Head Office, Market Area and Industry Position

9.9.2 Shanghai Microport Ep Medtech Co.,Ltd. Company Profile and Main Business

9.9.3 Shanghai Microport Ep Medtech Co.,Ltd. Renal Denervation (RDN) Therapy Models, Specifications and Application

9.9.4 Shanghai Microport Ep Medtech Co.,Ltd. Renal Denervation (RDN) Therapy Revenue and Gross Margin, 2018-2023

9.9.5 Shanghai Microport Ep Medtech Co.,Ltd. Recent Developments

9.10 Cryofocus Medtech

9.10.1 Cryofocus Medtech Company Information, Head Office, Market Area and Industry Position

9.10.2 Cryofocus Medtech Company Profile and Main Business

9.10.3 Cryofocus Medtech Renal Denervation (RDN) Therapy Models, Specifications and Application

9.10.4 Cryofocus Medtech Renal Denervation (RDN) Therapy Revenue and Gross Margin, 2018-2023

9.10.5 Cryofocus Medtech Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Renal Denervation (RDN) Therapy Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why are some of the most well-known companies left out of the Renal Denervation (RDN) Therapy Market study?
The Renal Denervation (RDN) Therapy study includes a diverse group of participants, including both market leaders and up-and-comers. Contact our sales representative to receive a complete list of companies covered in the study.
What is the forecasted growth rate of the Renal Denervation (RDN) Therapy Market?
The Renal Denervation (RDN) Therapy Market is expected to grow at a moderate CAGR during the forecast period of 2025 to 2030.
Where does the Renal Denervation (RDN) Therapy Industry stands in terms of scaling end-use implementations?
According to the Renal Denervation (RDN) Therapy Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
How is the competitive landscape for the Renal Denervation (RDN) Therapy Market defined?
Companies in the Renal Denervation (RDN) Therapy Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Renal Denervation (RDN) Therapy Market's trajectory and future outlook.